There are 3,981 results relating to "O"
|
Last updated:
9 December 2024
ASH Scotland response to Scottish Parliament Health Committee TVB LCM 09 Dec 2024 FINAL
The following figures detail smoking prevalence amongst young people in Scotland: ii o Health Behaviour in School-aged Children (HBSC) 2022 Ever smoking 15-year-olds: 20% 13-year-olds: 6% 11-year-olds: 1% Current smoking (smoked in the past 30 days) 15-year-olds: 11% 13-year-olds: 3% o The Health Behaviour in School-aged Children indicated that the decline in smoking prevalence among young people in Scotland has stalled since around 2018. o Although the Scottish Health Survey showed a smoking decline among all adults from 17% in 2019 to 15% in 2022, it, however, also showed smoking prevalence increased by 8% among young men (aged 16-24) from 14% to 22%.
Last updated:
7 November 2024
Teach Learn Play report
Original target number of primary schools (n~90) Accessible Small Remote Small Large Urban Other Urban Accessible Rural Remote Rural PRI Town Town l l l l l l s a a a a a a l r r r r r r d d d d d d r r r r r r o u u u u u u Rolls at e e e e e e t t t t t t e e e e e e f f f f f f o s s s s s s R R R R R R e e e e e e b b b b b b o o o o o o / / / / / / o o o o o o h g g g g g g Sep r r r r r r c m m m m m m n n n n n n p p p p p p % % % % s % % a a a a a a a a a a a a u u u u u u o o o o o o t t t t t t l r r r r r r b b b b b b l N N N N N N 2011 r r r r r r P P P P P P A U U U U U U <50 435 0 0% 0 8 2% 1 7 4% 0 3 4% 0 154 35% 7 263 64% 11 50‐99 279 14 3% 1 27 5% 2 18 11% 1 8 12% 0 119 27% 5 93 23% 4 100‐199 534 143 29% 6 163 32% 7 43 27% 2 21 30% 1 125 29% 6 39 9% 2 200‐299 448 162 33% 7 169 33% 7 55 35% 2 20 29% 1 26 6% 1 16 4% 1 300‐399 289 129 26% 6 112 22% 5 25 16% 1 13 19% 1 10 2% 0 0 0% 0 400+ 96 47 9% 2 33 6% 1 9 6% 0 4 6% 0 3 1% 0 0 0% 0 Totals 2081 495 100% 22 512 100% 23 157 100% 6 69 100% 3 437 100% 19 411 100% 18 22 http://www.scotland.gov.uk/Topics/Statistics/Browse/School-Education/schoolcontactdetails [accessed 18/6/12] 31 Table 32.
Last updated:
20 November 2023
Minute of the meeting held on 8 June 2022
o stimulating demand rather than supply – is this a fair assessment of policy?
Last updated:
28 April 2025
BillTeamtoConv_NEB 23 April 2025
As set out in table 12 of the Financial Memo which accompanied the Bill, on average 26 VDLs are issued annually across Scotland. The Vict o ria Qu a y , Ed inb u r gh EH6 6QQ w w w .go v .s co t cost of the licence ranges from £0 to £812, the cost on average is £190.45.
Last updated:
24 May 2023
Minutes of the meeting held on 1 February 2023
. • As its 10-year anniversary approaches, the strategy is due a refresh and engagement work with stakeholders is now being conducted. This includes: o A series of “deep dive conversations” with See Hear Leads. o Involving people with lived and living experience through a new network being set up by the Scottish Sensory Hub. o Third sector sensory loss organisations involvement including a Scottish Government Sensory Loss in Social Care Advisory group, with its first meeting in March 2023. o Establishing a cross-policy network of over 80 colleagues who have an interest in sensory loss and work across Scottish Government departments. o Holding a workshop on the See Hear strategy at the upcoming Scottish Vision Strategy (SVS) conference on 8 March 2023. o Opportunities for engaging with the deaf and deaf blindness sectors are also being considered. o Key findings so far from the engagement work undertaken with See Hear Leads are listed in Susan’s full presentation circulated with the minutes. o Key policy developments since 2014 also need to be included in the renewed strategy.
Last updated:
3 May 2023
Minutes of the meeting held on 1 February 2023
. • As its 10-year anniversary approaches, the strategy is due a refresh and engagement work with stakeholders is now being conducted. This includes: o A series of “deep dive conversations” with See Hear Leads. o Involving people with lived and living experience through a new network being set up by the Scottish Sensory Hub. 4 o Third sector sensory loss organisations involvement including a Scottish Government Sensory Loss in Social Care Advisory group, with its first meeting in March 2023. o Establishing a cross-policy network of over 80 colleagues who have an interest in sensory loss and work across Scottish Government departments. o Holding a workshop on the See Hear strategy at the upcoming Scottish Vision Strategy (SVS) conference on 8 March 2023. o Opportunities for engaging with the deaf and deaf blindness sectors are also being considered. o Key findings so far from the engagement work undertaken with See Hear Leads are listed in Susan’s full presentation circulated with the minutes. o Key policy developments since 2014 also need to be included in the renewed strategy.
Cross-Party Groups
Last updated:
21 August 2025
Crofting
Alastair Culbertson,
Andy Holt,
Ann Bruce,
Billy Neilson,
Brendan O’Hanrahan,
David Atkinson,
David Cameron,
David Skene,
Donald Bruce,
Donald MacKinnon,
Donald Meek,
Douglas Coulter,
Donald Murdie,
Eilidh Ross,
Eleanor Arthur,
Eleanor Garty,
Fiona Mackenzie,
Gwyn Jones,
Helen O’Keefe,
Henry Graham,
Iain MacKinnon,
Jamie McGrigor,
Jamie McIntyre,
Jim McPherson,
John Maughan,
John Norman Macleod,
John Toal,
Kirsty McColl,
Lena Horch,
Lorna Murray,
Lorne MacLeod,
Lucy Beattie,
Marcus MacDonald,
Michelle Henley,
Murray McCheyne,
Paddy Zakaria,
Phil Knott,
Philip Coghill,
Rebecca Robson,
Robin Haig,
Rosemary Champion,
Sandy Murray,
Tom Gray,
Yvonne White.
Committees
Published:
18 November 2021
University of Dundee submission of 18 November 2021
University of Dundee submission of 18 November 2021.
PE1723/O – Essential tremor treatment in Scotland .
Last updated:
1 February 2023
Stage 1 DPLRC Questions SG Response Charities Regulation and Administration Scotland Bill signed
It is anticipated that there may be other changes of circumstances which would Vict o ria Qu a y , Ed inb u r gh EH6 αβχδεφγηιϕ a b c d abcdefg α 6QQ w w w .go v .s co t 5 prompt a review of the list of factors that are or are not relevant to the question of whether an applicant has a connection to Scotland.
Last updated:
22 April 2022
Minutes of the CPG meeting on Medicinal Cannabis on 10th November 2021
Have to treat it as a plant, as a botanical study, and find other perfectly good ways of studying it such as observational trials. o May not be as robust, but the only to actually measure efficacy. o Not saying there is enough evidence, we have a lot to come. o BUT – for patients who have reached the end of the road in terms of conventional treatment should be given access. o It is not suitable for everyone, and does not work for every symptom in the same way, but crucially it is safe. o RISKS: are minimal if prescribed Guidance ➢ Doctors tend to look at guidance – NICE has been unhelpful, looked at it from a pharmaceutical paradigm, backtracked only under threat of court action in regards epilepsy. ➢ Other guidance such as the British Paediatric Neurological Association also very strict, no prescribing recommendation and have gone so far as to say children should be taken off their current cannabis prescription and put on the GW Pharma MHRA approved Epiodylex.
